CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations
Open accessThe DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index; none of the 42 sources its claims cite is checked for support yet.
Abstract
CBS domains are defined as sequence motifs that occur in several different proteins in all kingdoms of life. Although thought to be regulatory, their exact functions have been unknown. However, their importance was underlined by findings that mutations in conserved residues within them cause a variety of human hereditary diseases, including (with the gene mutated in parentheses): Wolff-Parkinson-White syndrome (gamma 2 subunit of AMP-activated protein kinase); retinitis pigmentosa (IMP dehydrogenase-1); congenital myotonia, idiopathic generalized epilepsy, hypercalciuric nephrolithiasis, and classic Bartter syndrome (CLC chloride channel family members); and homocystinuria (cystathionine beta-synthase). AMP-activated protein kinase is a sensor of cellular energy status that is activated by AMP and inhibited by ATP, but the location of the regulatory nucleotide-binding sites (which are prime targets for drugs to treat obesity and diabetes) was not characterized. We now show that tandem pairs of CBS domains from AMP-activated protein kinase, IMP dehydrogenase-2, the chloride channel CLC2, and cystathionine beta-synthase bind AMP, ATP, or S-adenosyl methionine,while mutations that cause hereditary diseases impair this binding. This shows that tandem pairs of CBS domains act, in most cases, as sensors of cellular energy status and, as such, represent a newly identified class of binding domain for adenosine derivatives.
Overview
CoChat Summary
## TL;DR
This paper shows that tandem CBS domain pairs act as allosteric binding modules for adenosine-related ligands, including AMP and ATP in AMPK, ATP in IMPDH and CLC2, and SAM in cystathionine β-synthase. It also shows that disease-associated mutations in these domains weaken ligand binding and, in AMPK, impair AMP-dependent activation.
## Key findings
- For AMPKγ2, the isolated CBS1-2 pair bound 1 AMP molecule with Kd = 53 ± 5 µM, and the CBS3-4 pair bound 1 AMP molecule with Kd = 104 ± 10 µM; the full CBS1-4 construct bound 2 AMP molecules with B0.5 = 61 ± 2 µM and Hill coefficient = 2.2 ± 0.1.
- Disease mutations increased AMP binding constants for AMPKγ2 CBS constructs; for CBS1-4, B0.5 for AMP rose from 61 ± 2 µM (WT) to 158 ± 9 µM (R302Q), 725 ± 36 µM (H383R), 1,360 ± 47 µM (T400N), and 2,800 ± 220 µM (R531G).
- In recombinant α1β1γ2 AMPK heterotrimers, the A0.5 for AMP activation increased in the same order as binding defects: WT 7 ± 3 µM, L ins 9 ± 4 µM, R302Q 23 ± 6 µM, H383R 51 ± 40 µM, T400N 95 ± 32 µM, and R531G >100 µM; the paper also states the WT α1β1γ1, α1β1γ2, and α1β1γ3 complexes were stimulated 3.3-fold, 7.0-fold, and 1.5-fold by AMP, respectively.
- Other CBS-domain proteins showed the same pattern: IMPDH2 CBS domains bound 1 ATP molecule with Kd = 54 ± 6 µM, while the R224P mutation increased this to 450 ± 36 µM; full-length IMPDH2 bound ATP with B0.5 = 770 ± 50 µM and ATP stimulated IMPDH activity more than fourfold with A0.5 = 0.44 ± 0.05 mM and Hill coefficient = 1.3 ± 0.1; CLC2 CBS domains bound ATP with Kd = 1.06 ± 0.08 mM, and pathogenic mutations raised this to 10.4-fold (G715E) and 14-fold (G826D) higher; cystathionine β-synthase CBS domains bound SAM with Kd = 34 ± 2 µM, and D444N increased this 15-fold to 510 ± 70 µM.
## Methods
- The study cloned CBS-domain constructs from AMPKγ1, γ2, and γ3, IMPDH2, CLC2, and cystathionine β-synthase, expressed them mainly as GST fusions in bacteria, and introduced disease mutations by site-directed mutagenesis.
- Ligand binding was measured using radiolabeled AMP, ATP, or SAM with rapid filtration, and data were fit to single-site or Hill binding models; AMPK heterotrimers were also expressed in CCL13 cells and assayed for AMP-dependent activity after rapid or slow lysis.
- IMPDH2 enzymatic activity was measured by NADH formation at 340 nm in the presence or absence of ATP.
## Limitations
- The paper itself notes several unresolved issues: AMP activation of AMPK heterotrimers occurred at concentrations about tenfold lower than the B0.5 values for AMP binding to isolated CBS1-4 constructs; the three AMPKγ isoforms differed in AMP binding (20 µM, 53 µM, 125 µM) but the heterotrimers differed mainly in degree of stimulation rather than A0.5; and it states that further work is required to determine whether AMPK uses a mechanism similar to cAMP-dependent protein kinase.
- The text makes evident that some activation estimates are less precise because AMP could not be tested above 100 µM in heterotrimer assays, and the authors say the A0.5 values for H383R and T400N are less accurate, while no A0.5 could be obtained for R531G; this is an evidence-based limitation from the assay design.
- The study used purified domains and recombinant proteins in bacteria or cell culture, so direct in vivo physiology is not tested here; this is evident from the methods and experimental system, not explicitly stated as a limitation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 23 Not checked · 78 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“| AMPK- γ 2 | CBS1-2 (WT) | 1 | 53 ± 5 | - | 175 ± 20 | - |”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We now show that tandem pairs of CBS domains from AMP-activated protein kinase, IMP dehydrogenase-2, the chloride channel CLC2, and cystathionine β -synthase bind AMP, ATP, or S -adenosyl methionine,while mutations that cause hereditary diseases impair this binding.”
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We now show that tandem pairs of CBS domains from AMP-activated protein kinase, IMP dehydrogenase-2, the chloride channel CLC2, and cystathionine β -synthase bind AMP, ATP, or S -adenosyl methionine,while mutations that cause hereditary diseases impair this binding.”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mutant still bound AMP, but the K d increased 15-fold (Figure 1c and Table 1).”
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The K d for L ins was not significantly different from that for the WT.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
49 more claims
Create a free account to see all 101 claims and to verify the 42 references still open.
- It may state two separate claims as one. 38
- The quote only partly states this claim. 1
- Probably not a substantial claim. 12
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Figure 4
“Binding of ATP by GST fusions of the isolated CBS domain pair (residues 112-232) ( a ) and full-length IMPDH2 (residues 1-514) ( b ).”
§ Methods
“The IMPDH2 constructs were polyhistidine-tagged and were purified on chelating Sepharose (Pharmacia, Chalfont St. Giles, United Kingdom) charged with 50 mM CoCl2 according to the manufacturer's instructions.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Discussion
“the four tandem pairs of CBS domains in the γ subunits of AMPK provide two allosteric binding sites for AMP and ATP in the heterotrimeric complex”
§ Introduction
“the three γ subunit isoforms of AMPK, and their homologues in lower eukaryotes, are unique among eukaryotic proteins in having four tandem domains”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Figure 3
“For the constructs from γ 1, γ 2, and γ 3, the B0.5 values for AMP were 20, 53, and 125 µ m, respectively.”
§ Methods
“| | CBS1-4 (WT) | 2 | 61 ± 2 | 2.2 ± 0.1 | 257 ± 14 | 2.2 ± 0.2 |”
Citations
Cites
1 retracted
Haug, K., Warnstedt, M., Alekov, A. K., Sander, T., Ramírez, A., Poser, B., Maljevic, S., Hebeisen, S., Kubisch, C., Rebstock, J., et al. (2003) · Nature Genetics · doi:10.1038/ng1121 · Cited by 294
RetractedThe Pfam Protein Families Database
Bateman, A. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.276 · Cited by 14,000
Comparative Protein Modelling by Satisfaction of Spatial Restraints
Šali, A., & Blundell, T. L. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1626 · Cited by 12,977
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Nicholls, A., Sharp, K. A., & Honig, B. (1991) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340110407 · Cited by 5,240
Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. (2002) · Nature Medicine · doi:10.1038/nm788 · Cited by 4,238
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Minokoshi, Y., Kim, Y.-B., Peroni, O. D., Fryer, L. G. D., Müller, C., Carling, D., & Kahn, B. B. (2002) · Nature · doi:10.1038/415339a · Cited by 2,053 · cited 1×
“It is also activated by the antidiabetic drugs metformin and rosiglitazone (21–23), and by the adipocyte-derived hormones leptin and adiponectin (24, 25).”
BackgroundCorton, J. M., Gillespie, J. G., Hawley, S. A., & Hardie, D. G. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.0558k.x · Cited by 1,230
Self-citationFryer, L. G. D., Parbu-Patel, A., & Carling, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202489200 · Cited by 1,029
Merrill, G. F., Kurth, E. J., Hardie, D. G., & Winder, W. W. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.6.e1107 · Cited by 1,025
Self-citation
Research works printed but not linked: 4
- Winder, 1996, Am. J. Physiol., 270, E299
- Merrill, 1997, Am. J. Physiol., 273, E1107
- Winder, 1999, Am. J. Physiol., 277, E1
- Hardie, 2000, Methods Mol. Biol., 99, 63
Cited by
AMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602
Self-citationKahn, B. B., Alquier, T., Carling, D., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2004.12.003 · Cited by 2,799
“, Wolff-Parkinson-White syndrome (WPWS), which is usually associated with hypertrophic cardiomyopathy (HCM) (Scott et al., 2004).”
BackgroundResultSelf-citationAMP-activated/SNF1 protein kinases: conserved guardians of cellular energy
Hardie, D. G. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2249 · Cited by 2,216
Self-citationSteinberg, G. R., & Kemp, B. E. (2009) · Physiological Reviews · doi:10.1152/physrev.00011.2008 · Cited by 1,637
AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function
Hardie, D. G. (2011) · Genes & Development · doi:10.1101/gad.17420111 · Cited by 1,638
Self-citationHawley, S. A., Pan, D. A., Mustard, K. J., Ross, L., Bain, J., Edelman, A. M., Frenguelli, B. G., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.009 · Cited by 1,589
Self-citationAMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling
Towler, M. C., & Hardie, D. G. (2007) · Circulation Research · doi:10.1161/01.res.0000256090.42690.05 · Cited by 1,253
Self-citationAMPK: Sensing Glucose as well as Cellular Energy Status
Lin, S.-C., & Hardie, D. G. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.10.009 · Cited by 1,191
Self-citationThe AMP-activated protein kinase pathway – new players upstream and downstream
Hardie, D. G. (2004) · Journal of Cell Science · doi:10.1242/jcs.01540 · Cited by 1,143
Self-citationThe LKB1 tumor suppressor negatively regulates mTOR signaling
Shaw, R. J., Bardeesy, N., Manning, B. D., Lopez, L., Kosmatka, M., DePinho, R. A., & Cantley, L. C. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.007 · Cited by 1,077
Chemical Biology of H2S Signaling through Persulfidation
Filipovic, M. R., Zivanovic, J., Alvarez, B., & Banerjee, R. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00205 · Cited by 1,046
New insights into activation and function of the AMPK
Steinberg, G. R., & Hardie, D. G. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00547-x · Cited by 1,006
Self-citationCool, B., Zinker, B., Chiou, W., Kifle, L., Cao, N., Perham, M., Dickinson, R., Adler, A., Gagne, G., Iyengar, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.05.005 · Cited by 925
AMPK and SIRT1: a long-standing partnership?
Ruderman, N. B., Julia Xu, X., Nelson, L., Cacicedo, J. M., Saha, A. K., Lan, F., & Ido, Y. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00745.2009 · Cited by 903
AMPK: An Energy-Sensing Pathway with Multiple Inputs and Outputs
Hardie, D. G., Schaffer, B. E., & Brunet, A. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2015.10.013 · Cited by 859
Self-citationAMP-Activated Protein Kinase – Development of the Energy Sensor Concept
Hardie, D. G., Hawley, S. A., & Scott, J. W. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.108944 · Cited by 813
Self-citationAMPK and TOR: The Yin and Yang of Cellular Nutrient Sensing and Growth Control
González, A., Hall, M. N., Lin, S.-C., & Hardie, D. G. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.01.015 · Cited by 797
Self-citationLKB1-Dependent Signaling Pathways
Alessi, D. R., Sakamoto, K., & Bayascas, J. R. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142702 · Cited by 788
Use of Cells Expressing γ Subunit Variants to Identify Diverse Mechanisms of AMPK Activation
Hawley, S. A., Ross, F. A., Chevtzoff, C., Green, K. A., Evans, A., Fogarty, S., Towler, M. C., Brown, L. J., Ogunbayo, O. A., Evans, A. M., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.04.001 · Cited by 773
“We have shown previously that this mutation interferes with the binding to the g2 subunit not only of the activating ligand, AMP, but also of the inhibitory ligand, ATP (Scott et al., 2004).”
BackgroundInfluentialSelf-citationAMPK: a key regulator of energy balance in the single cell and the whole organism
Hardie, D. G. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.116 · Cited by 703
Self-citationInvestigating the mechanism for AMP activation of the AMP-activated protein kinase cascade
Sanders, M. J., Grondin, P. O., Hegarty, B. D., Snowden, M. A., & Carling, D. (2007) · Biochemical Journal · doi:10.1042/bj20061520 · Cited by 666
Bonora, M., Patergnani, S., Rimessi, A., De Marchi, E., Suski, J. M., Bononi, A., Giorgi, C., Marchi, S., Missiroli, S., Poletti, F., et al. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9305-8 · Cited by 644
“The β-subunit accounts for a region targeting AMPK to glycogen particles [21], and the γ-subunit is committed to the detection of the AMP/ATP ratio through four particular domains of cystathionine β-synthase [22].”
BackgroundDomestic-animal genomics: deciphering the genetics of complex traits
Andersson, L., & Georges, M. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1294 · Cited by 623
Structural basis for AMP binding to mammalian AMP-activated protein kinase
Xiao, B., Heath, R., Saiu, P., Leiper, F. C., Leone, P., Jing, C., Walker, P. A., Haire, L., Eccleston, J. F., Davis, C. T., et al. (2007) · Nature · doi:10.1038/nature06161 · Cited by 591
AMPK—Sensing Energy while Talking to Other Signaling Pathways
Hardie, D. G. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.09.013 · Cited by 583
Self-citationHedbacker, K. (2008) · Frontiers in Bioscience · doi:10.2741/2854 · Cited by 554
“Snf4 contains two pairs of cystathionine-beta-synthase (CBS) repeats (75), called Bateman domains (Figure 2), which in various proteins have been shown to bind adenosine derivatives (76, 77).”
BackgroundThe Role of Autophagy in the Heart
Sciarretta, S., Maejima, Y., Zablocki, D., & Sadoshima, J. (2018) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021317-121427 · Cited by 547
Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction
Sakamoto, K., McCarthy, A., Smith, D., Green, K. A., Grahame Hardie, D., Ashworth, A., & Alessi, D. R. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600667 · Cited by 544
Self-citationGowans, G. J., Hawley, S. A., Ross, F. A., & Hardie, D. G. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.08.019 · Cited by 531
“The regulatory adenine nucleotide-binding sites on the g subunits are formed by four tandemCBS repeats (Scott et al., 2004).”
BackgroundSelf-citationAMPK: A Key Sensor of Fuel and Energy Status in Skeletal Muscle
Hardie, D. G., & Sakamoto, K. (2006) · Physiology · doi:10.1152/physiol.00044.2005 · Cited by 520
Self-citationHydrogen sulfide as a gasotransmitter
Gadalla, M. M., & Snyder, S. H. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06580.x · Cited by 498
AMPK in skeletal muscle function and metabolism
Kjøbsted, R., Hingst, J. R., Fentz, J., Foretz, M., Sanz, M., Pehmøller, C., Shum, M., Marette, A., Mounier, R., Treebak, J. T., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201700442r · Cited by 496
Suter, M., Riek, U., Tuerk, R., Schlattner, U., Wallimann, T., & Neumann, D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606357200 · Cited by 477
AMPK: A Target for Drugs and Natural Products With Effects on Both Diabetes and Cancer
Hardie, D. G. (2013) · Diabetes · doi:10.2337/db13-0368 · Cited by 458
Self-citationCLC Chloride Channels and Transporters: Structure, Function, Physiology, and Disease
Jentsch, T. J., & Pusch, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00047.2017 · Cited by 448
Exposure to hydrogen peroxide induces oxidation and activation of AMP-activated protein kinase
Zmijewski, J. W., Banerjee, S., Bae, H., Friggeri, A., Lazarowski, E. R., & Abraham, E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.143685 · Cited by 441
Mechanism of Action of A-769662, a Valuable Tool for Activation of AMP-activated Protein Kinase
Göransson, O., McBride, A., Hawley, S. A., Ross, F. A., Shpiro, N., Foretz, M., Viollet, B., Hardie, D. G., & Sakamoto, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706536200 · Cited by 435
Self-citationThe Glycogen-Binding Domain on the AMPK β Subunit Allows the Kinase to Act as a Glycogen Sensor
McBride, A., Ghilagaber, S., Nikolaev, A., & Hardie, D. G. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2008.11.008 · Cited by 432
“The g subunits contain tandem domains that bind the regulatory nucleotides AMP and ATP in a mutually exclusive manner (Scott et al., 2004; Townley and Shapiro, 2007; Xiao et al., 2007).”
Self-citationIMP Dehydrogenase: Structure, Mechanism, and Inhibition
Hedstrom, L. (2009) · Chemical Reviews · doi:10.1021/cr900021w · Cited by 428
Miller, E. J., Li, J., Leng, L., McDonald, C., Atsumi, T., Bucala, R., & Young, L. H. (2008) · Nature · doi:10.1038/nature06504 · Cited by 429
AMP-activated protein kinase: nature's energy sensor
Carling, D., Mayer, F. V., Sanders, M. J., & Gamblin, S. J. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.610 · Cited by 387
AMP-Activated Protein Kinase as a Drug Target
Hardie, D. G. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105304 · Cited by 407
Self-citationCLC Chloride Channels and Transporters: From Genes to Protein Structure, Pathology and Physiology
Jentsch, T. J. (2008) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230701829110 · Cited by 405
The role of autophagy in the heart
Nishida, K., Kyoi, S., Yamaguchi, O., Sadoshima, J., & Otsu, K. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.163 · Cited by 393
AMP ‐activated protein kinase: a cellular energy sensor that comes in 12 flavours
Ross, F. A., MacKintosh, C., & Hardie, D. G. (2016) · The FEBS Journal · doi:10.1111/febs.13698 · Cited by 381
Self-citationSNF1/AMPK/SnRK1 kinases, global regulators at the heart of energy control?
Polge, C., & Thomas, M. (2007) · Trends in Plant Science · doi:10.1016/j.tplants.2006.11.005 · Cited by 381
AMPK inhibition in health and disease
Viollet, B., Horman, S., Leclerc, J., Lantier, L., Foretz, M., Billaud, M., Giri, S., & Andreelli, F. (2010) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2010.488215 · Cited by 383
AMP-activated protein kinase: new regulation, new roles?
Carling, D., Thornton, C., Woods, A., & Sanders, M. J. (2012) · Biochemical Journal · doi:10.1042/bj20120546 · Cited by 379
AMP-Activated Protein Kinase: A Target for Drugs both Ancient and Modern
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.08.019 · Cited by 372
Self-citationSensing of energy and nutrients by AMP-activated protein kinase
Hardie, D. G. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.001925 · Cited by 372
Self-citationLoss of the chloride channel ClC‐7 leads to lysosomal storage disease and neurodegeneration
Kasper, D., Planells‐Cases, R., Fuhrmann, J. C., Scheel, O., Zeitz, O., Ruether, K., Schmitt, A., Poët, M., Steinfeld, R., Schweizer, M., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600576 · Cited by 368
AMP-Activated Protein Kinase in the Heart: Role During Health and Disease
Arad, M., Seidman, C. E., & Seidman, J. G. (2007) · Circulation Research · doi:10.1161/01.res.0000258446.23525.37 · Cited by 362
Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer
Fogarty, S., & Hardie, D. G. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.09.012 · Cited by 350
Self-citationXie, M., Zhang, D., Dyck, J. R. B., Li, Y., Zhang, H., Morishima, M., Mann, D. L., Taffet, G. E., Baldini, A., Khoury, D. S., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604708103 · Cited by 347
Nutrient-Sensing Mechanisms across Evolution
Chantranupong, L., Wolfson, R. L., & Sabatini, D. M. (2015) · Cell · doi:10.1016/j.cell.2015.02.041 · Cited by 325
Oakhill, J. S., Chen, Z.-P., Scott, J. W., Steel, R., Castelli, L. A., Ling, N., Macaulay, S. L., & Kemp, B. E. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009705107 · Cited by 320
Self-citationBarnes, B. R., Marklund, S., Steiler, T. L., Walter, M., Hjälm, Amarger, V., Mahlapuu, M., Leng, Y., Johansson, C., Galuska, D., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405533200 · Cited by 317
Regulation of HMG-CoA reductase in mammals and yeast
Burg, J. S., & Espenshade, P. J. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.07.002 · Cited by 303
“The c subunit contains four tandem cystathionine b-synthase (CBS) domains, which bind adenosine nucleotides and are thought to participate in energy sensing [49].”
Zhao, X., Zmijewski, J. W., Lorne, E., Liu, G., Park, Y.-J., Tsuruta, Y., & Abraham, E. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90210.2008 · Cited by 301
Sakamoto, K., Göransson, O., Hardie, D. G., & Alessi, D. R. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00074.2004 · Cited by 299
“Phenformin stimulates AMPK without affecting the AMP or the ADP/ATP ratio in cells (7, 12) and does not influence the phosphorylation of the heterotrimeric AMPK complex by LKB1 in vitro (11).”
BackgroundInfluentialSelf-citationNatural history of S-adenosylmethionine-binding proteins
Kozbial, P. Z., & Mushegian, A. R. (2005) · BMC Structural Biology · doi:10.1186/1472-6807-5-19 · Cited by 297
The regulation of AMP-activated protein kinase by upstream kinases
Carling, D., Sanders, M. J., & Woods, A. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.124 · Cited by 287
AMP ‐activated protein kinase: a key regulator of energy balance with many roles in human disease
Grahame Hardie, D. (2014) · Journal of Internal Medicine · doi:10.1111/joim.12268 · Cited by 285
Targeting the AMPK pathway for the treatment of Type 2 diabetes
Viollet, B. (2009) · Frontiers in Bioscience · doi:10.2741/3460 · Cited by 278
Zhang, Y.-L., Guo, H., Zhang, C.-S., Lin, S.-Y., Yin, Z., Peng, Y., Luo, H., Shi, Y., Lian, G., Zhang, C., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.09.005 · Cited by 270
Broeckx, T., Hulsmans, S., & Rolland, F. (2016) · Journal of Experimental Botany · doi:10.1093/jxb/erw416 · Cited by 267
AMP-activated protein kinase: maintaining energy homeostasis at the cellular and whole-body levels
Hardie, D. G. (2014) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071812-161148 · Cited by 281
Self-citationRole of AMPK in skeletal muscle metabolic regulation and adaptation in relation to exercise
Jørgensen, S. B., Richter, E. A., & Wojtaszewski, J. F. P. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.109942 · Cited by 261
New roles for the LKB1→AMPK pathway
Hardie, D. G. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.01.006 · Cited by 255
Self-citationScott, J. W., van Denderen, B. J. W., Jorgensen, S. B., Honeyman, J. E., Steinberg, G. R., Oakhill, J. S., Iseli, T. J., Koay, A., Gooley, P. R., Stapleton, D., et al. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.10.005 · Cited by 252
Self-citationWitczak, C. A., Sharoff, C. G., & Goodyear, L. J. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8244-6 · Cited by 251
CBS domains: structure, function, and pathology in human proteins
Ignoul, S., & Eggermont, J. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00282.2005 · Cited by 247
Emerging Role of cAMP/AMPK Signaling
Aslam, M., & Ladilov, Y. (2022) · Cells · doi:10.3390/cells11020308 · Cited by 241
“In energy-replete conditions (low AMP/ATP ratio), the CBS domains in the γ-subunit of AMPK are occupied by ATP, exposing the Thr172 of the α-subunit for easy access to phosphatases that keep it in a nonphosphorylated, inactive state.”
BackgroundInfluentialMechanisms of regulation of SNF1/AMPK/SnRK1 protein kinases
Crozet, P., Margalha, L., Confraria, A., Rodrigues, A., Martinho, C., Adamo, M., Elias, C. A., & Baena-González, E. (2014) · Frontiers in Plant Science · doi:10.3389/fpls.2014.00190 · Cited by 234
S -adenosylmethionine stabilizes cystathionine β-synthase and modulates redox capacity
Prudova, A., Bauman, Z., Braun, A., Vitvitsky, V., Lu, S. C., & Banerjee, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509531103 · Cited by 232
Miles, E. W., & Kraus, J. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400005200 · Cited by 235
Neutrophil-Derived MMP-8 Drives AMPK-Dependent Matrix Destruction in Human Pulmonary Tuberculosis
Ong, C. W. M., Elkington, P. T., Brilha, S., Ugarte-Gil, C., Tome-Esteban, M. T., Tezera, L. B., Pabisiak, P. J., Moores, R. C., Sathyamoorthy, T., Patel, V., et al. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004917 · Cited by 233
PHYSIOLOGICAL FUNCTIONS OF CLC Cl−CHANNELS GLEANED FROM HUMAN GENETIC DISEASE AND MOUSE MODELS
Jentsch, T. J., Poët, M., Fuhrmann, J. C., & Zdebik, A. A. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.67.032003.153245 · Cited by 228
Banerjee, R., & Zou, C.-G. (2005) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2004.08.037 · Cited by 225
The Cyclic Dinucleotide c-di-AMP Is an Allosteric Regulator of Metabolic Enzyme Function
Sureka, K., Choi, P. H., Precit, M., Delince, M., Pensinger, D. A., Huynh, T. N., Jurado, A. R., Goo, Y. A., Sadilek, M., Iavarone, A. T., et al. (2014) · Cell · doi:10.1016/j.cell.2014.07.046 · Cited by 219
AMPK–mTOR Signaling and Cellular Adaptations in Hypoxia
Chun, Y., & Kim, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189765 · Cited by 218
Role of AMP‐activated protein kinase in the metabolic syndrome and in heart disease
Hardie, D. G. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.018 · Cited by 217
Self-citationPhosphorylation by Akt within the ST loop of AMPK-α1 down-regulates its activation in tumour cells
Hawley, S. A., Ross, F. A., Gowans, G. J., Tibarewal, P., Leslie, N. R., & Hardie, D. G. (2014) · Biochemical Journal · doi:10.1042/bj20131344 · Cited by 215
Self-citationZhou, L., Deepa, S. S., Etzler, J. C., Ryu, J., Mao, X., Fang, Q., Liu, D. D., Torres, J. M., Jia, W., Lechleiter, J. D., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.028357 · Cited by 212
AMPK and autophagy in glucose/glycogen metabolism
Ha, J., Guan, K.-L., & Kim, J. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2015.08.002 · Cited by 211
Mechanisms of human inherited epilepsies
Reid, C. A., Berkovic, S. F., & Petrou, S. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.09.016 · Cited by 210
AMP-activated protein kinase: balancing the scales
Carling, D. (2005) · Biochimie · doi:10.1016/j.biochi.2004.10.017 · Cited by 202
Lysosomal storage disease upon disruption of the neuronal chloride transport protein ClC-6
Poët, M., Kornak, U., Schweizer, M., Zdebik, A. A., Scheel, O., Hoelter, S., Wurst, W., Schmitt, A., Fuhrmann, J. C., Planells-Cases, R., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606137103 · Cited by 199
AMPK functions as an adenylate charge-regulated protein kinase
Oakhill, J. S., Scott, J. W., & Kemp, B. E. (2012) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.12.006 · Cited by 200
Self-citationTran-Nguyen, L. T. T., Kube, M., Schneider, B., Reinhardt, R., & Gibb, K. S. (2008) · Journal of Bacteriology · doi:10.1128/jb.01301-07 · Cited by 201
Miller, V. J., Villamena, F. A., & Volek, J. S. (2018) · Journal of Nutrition and Metabolism · doi:10.1155/2018/5157645 · Cited by 199
Redox implications of AMPK-mediated signal transduction beyond energetic clues
Cardaci, S., Filomeni, G., & Ciriolo, M. R. (2012) · Journal of Cell Science · doi:10.1242/jcs.095216 · Cited by 197
Structural insight into the autoinhibition mechanism of AMP-activated protein kinase
Chen, L., Jiao, Z.-H., Zheng, L.-S., Zhang, Y.-Y., Xie, S.-T., Wang, Z.-X., & Wu, J.-W. (2009) · Nature · doi:10.1038/nature08075 · Cited by 194
Garcia-Roves, P. M., Osler, M. E., Holmström, M. H., & Zierath, J. R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805078200 · Cited by 190
AMP-activated protein kinase: Also regulated by ADP?
Hardie, D. G., Carling, D., & Gamblin, S. J. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2011.06.004 · Cited by 187
Self-citationStructural Basis for Glycogen Recognition by AMP-Activated Protein Kinase
Polekhina, G., Gupta, A., van Denderen, B. J. W., Feil, S. C., Kemp, B. E., Stapleton, D., & Parker, M. W. (2005) · Structure · doi:10.1016/j.str.2005.07.008 · Cited by 186
Salt, I. P., & Hardie, D. G. (2017) · Circulation Research · doi:10.1161/circresaha.117.309633 · Cited by 187
Self-citationGlycolysis: A multifaceted metabolic pathway and signaling hub
Kierans, S. J., & Taylor, C. T. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107906 · Cited by 198
The Hotdog fold: wrapping up a superfamily of thioesterases and dehydratases
Dillon, S. C., & Bateman, A. (2004) · BMC Bioinformatics · doi:10.1186/1471-2105-5-109 · Cited by 183
Crystal Structures of the Adenylate Sensor from Fission Yeast AMP-Activated Protein Kinase
Townley, R., & Shapiro, L. (2007) · Science · doi:10.1126/science.1137503 · Cited by 179
Metadata
- Authors
- Scott, J. W., Hawley, S. A., Green, K. A., Anis, M., Stewart, G., Scullion, G. A., Norman, D. G., & Hardie, D. G.
- Affiliations
- University of Dundee (GB)
- Venue
- Journal of Clinical Investigation
- Published
- 2004-01-15
- Volume
- 113
- Issue
- 2
- Pages
- 274-284
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC311435
- OpenAlex
- W2166714586
- Cited by
- 754
- References
- 56
- Citations by year
- 2026: 13 · 2025: 17 · 2024: 19 · 2023: 16 · 2022: 18 · 2021: 19 · 2020: 19 · 2019: 23 · 2018: 27 · 2017: 37 · 2016: 25 · 2015: 22 · 2014: 33 · 2013: 35 · 2012: 59
- FWCI
- 21.36
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion, other-oa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Wellcome Trust (QLG1-CT-2001-01488)
- European Commission
- Directorate for Biological Sciences
- Biotechnology and Biological Sciences Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Keywords
- CBS domain, energy sensing, AMPK, cystathionine beta-synthase, S-adenosylmethionine, pathogenic variants, genetic disorders, nucleotide binding site
- MeSH terms
- Adenosine, Adenosine Monophosphate, Adenosine Triphosphate, Allosteric Site, Animals, Binding Sites, Cloning, Molecular, DNA, Dose-Response Relationship, Drug, Escherichia coli, Glutathione Transferase, Humans, Kinetics, Ligands, Liver, Models, Molecular, Mutation, Plasmids, Protein Binding, Recombinant Fusion Proteins, Recombinant Proteins, Retinitis Pigmentosa, Polymerase Chain Reaction, Protein Structure, Tertiary, DNA, Complementary, Dimerization, Protein Isoforms, Amino Acid Motifs, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.